178 filings
Page 5 of 9
6-K
w1cm3 1ntsj72eiw9kgt
7 Oct 16
Update from Alcobra on Recent FDA Communications
12:00am
6-K
svzejtn
29 Sep 16
Alcobra Announces IND Clinical Hold Affecting the MDX Phase III MEASURE Study
12:00am
6-K
4d6ceyn kdw85a9
30 Aug 16
Current report (foreign)
12:00am
6-K
1b5l 22ak7i1goj
19 Jul 16
Current report (foreign)
12:00am
6-K
485z17bjp7spmyj0l
19 Jul 16
Alcobra Granted European Orphan Drug Designation for Metadoxine in Fragile X Syndrome
12:00am
6-K
vw5s 8omnuztk
8 Jun 16
Notice of Annual General Meeting of Shareholders
12:00am
6-K
80ldmr62p
18 May 16
Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update
12:00am
EFFECT
xog00fd
18 Mar 16
Notice of effectiveness
12:00am
CORRESP
1o12aq
16 Mar 16
Correspondence with SEC
12:00am
UPLOAD
rxhuy95xp3215y344m
15 Mar 16
Letter from SEC
12:00am
F-3
jocm6o783hopwra445u
4 Mar 16
Shelf registration (foreign)
12:00am
S-8
8ndgan
4 Mar 16
Registration of securities for employees
12:00am
6-K
09a4ce27
17 Feb 16
Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update
12:00am
424B5
bcq9p02al9g84e 6bh84
16 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
y4b w3c4igel
13 Nov 15
Alcobra Ltd. Prices Public Offering of Ordinary Shares
12:00am
6-K
eknya3h 8y6ju1sft
12 Nov 15
Alcobra Announces Third Quarter 2015 Financial Results and Provides Corporate Update
12:00am
424B5
f3kgbvy8s
12 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
ivrezau
12 Nov 15
Report of Foreign Private Issuer
12:00am
6-K
agbateru86 nys
21 Sep 15
Current report (foreign)
12:00am